Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Colorectal Cancer
Items per page
5
10
20
40
60
100
Title
Average Rating
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer.
50.00%
Todoxin, the immune stimulant from Serbia
86.36%
The present state of antineoplaston research (1)
90.00%
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications
90.00%
Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer.
60.00%
Sorafenib and radiation: A promising combination in colorectal and pancreas cancer
70.00%
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced
90.00%
Removed because of suspicion of scientific fraud: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.
10.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative....
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative..
80.00%
Randomized phase II trial of capecitabine versus capecitabine, low molecular weight heparin, and prednisone in refractory.......
70.00%
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.
70.00%
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer.
90.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities
50.00%
Nuts and green tea key to cancer treatment?
60.00%
Mycoplasma infections and different human carcinomas.
90.00%
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high...
80.00%
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
90.00%
Melatonin as biological response modifier in cancer patients.
80.00%
Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts.
70.00%
Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting".
60.00%
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.
70.00%
Homeopathy as a supportive therapy in cancer.
70.00%
Five novel mono-tetrahydrofuran ring acetogenins from the seeds of Annona muricata.
50.00%
Evaluation of the treatment of peritoneal carcinomatosis of colorectal cancer (CRC) with complete cytoreduction and hyperthe....
80.00%
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal ca. patients
70.00%
Complete remission of psoriasis following bevacizumab therapy for colon cancer.
60.00%
Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy)
80.00%
Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications.
70.00%
Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in---
80.00%
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal
50.00%
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glyc
60.00%
Artemisinin derivates in the treatment of Cancer
90.00%
Antitumor properties and modulation of antioxidant enzymes' activity by Aloe vera leaf active principles isolated via supercriti
80.00%
Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer.
80.00%
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
80.00%
Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses?
60.00%
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm).
70.00%
An Internet misadventure: bloodroot salve toxicity
80.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable metastatic colorectal carcinoma.
100.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable m
100.00%
A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose-Escalation, Safety Study of the Chemot
70.00%
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.
50.00%
A case of metronomic chemotherapy as an alternative cancer therapy for palliation
60.00%
To widen the setting of cancer patients who could benefit from metronomic capecitabine.
80.00%
Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal......
60.00%
Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a stu
70.00%
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib.
50.00%
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts.
40.00%
Anti-angiogenic therapies for metastatic colorectal cancer.
60.00%